← Eichor
Condition: Pten Hamartoma Syndrome Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pten Hamartoma Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Phase N/A · 1 location(s) · University Health Network, Toronto · NCT03702309
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast
Phase N/A · 12 location(s) · Sir Mortimer B. Davis - Jewish General Hospital · NCT06888388
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Phase N/A · 5 location(s) · Boston Children's Hospital · NCT02461446
Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants
Phase N/A · 1 location(s) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT06805734
Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268
Video Capsule Examination in Patients With Lynch Syndrome
NA · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT06712095
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Phase N/A · 3 location(s) · Universidad Nacional Autonoma de Mexico · NCT06523582
PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry
Phase N/A · 1 location(s) · Yale University · NCT06462430
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.